missing translation for 'onlineSavingsMsg'
Learn More

PT2399, MedChemExpress

Product Code. p-200097122
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16485166

Brand: Medchem Express HY108697

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC50 of 6 nM. PT2399 displays potent antitumor activity in vivo.

PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-2α PAS B domain with an IC50 of 6 nM. PT2399 displays potent antitumor activity in vivo.

Specifications

Chemical Name or Material PT2399
CAS 1672662-14-4
Color Off-White
Purity Grade Notes Research
Molecular Formula C17H10F5NO4S
Quantity 100 mg
Solubility Information DMSO : ≥ 200 mg/mL (476.96 mM)
SMILES N#CC1=CC(F)=CC(OC2=CC=C(S(=O)(C(F)F)=O)C3=C2CC(F)(F)[C@H]3O)=C1
Molecular Weight (g/mol) 419.32
Formula Weight 419.32
Percent Purity 99.83%
Grade Research
Physical Form Powder
For Use With (Application) Cancer-programmed cell death
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.